![]() MBX Biosciences MBX Biosciences is a clinical-stage biopharmaceutical company that develops novel precision peptide therapies for endocrine and metabolic disorders. | Standigm Standigm is a workflow artificial intelligence (AI) drug discovery company that generates therapeutic lead compounds. | ![]() Skyhawk Therapeutics Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression. | ||
Founding Date | Founding Date 2018 | Founding Date 2022 | Founding Date 2015 | Founding Date 2016 |
Type | Type Public | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Carmel, US HQ | Locations San Diego, US HQ | Locations KR HQ Cambridge, GB Cambridge, US | Locations Waltham, US HQ Basel, CH |
Employees | Employees 36 | Employees 22 | Employees 297% increase | Employees 673% decrease |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 82m (over 2 years ago) | Latest funding round $ 10m (about 5 years ago) | Latest funding round $ 40m (about 8 years ago) |
Total funding raised | Total funding raised $ 34.6m | Total funding raised $ 82m | Total funding raised $ 69.7m | Total funding raised $ 48m |

Kenai Therapeutics is a company that develops a drug discovery platform.
View companyStandigm is a workflow artificial intelligence (AI) drug discovery company that generates therapeutic lead compounds.
View company
Skyhawk Therapeutics is a drug discovery and development company focused on revolutionizing disease treatment with small molecules that correct RNA expression.
View company